Alternatively spliced ELAVL3 cryptic exon 4a causes ELAVL3 downregulation in ALS TDP-43 proteinopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Alternatively spliced ELAVL3 cryptic exon 4a causes ELAVL3 downregulation in ALS TDP-43 proteinopathy ; volume:147 ; number:1 ; day:30 ; month:5 ; year:2024 ; pages:1-4 ; date:6.2024
Acta neuropathologica ; 147, Heft 1 (30.5.2024), 1-4, 6.2024
- Urheber
-
Costantino, Isabel
Meng, Alex
Ravits, John
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-024-02732-y
- URN
-
urn:nbn:de:101:1-2408090922214.801583317671
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costantino, Isabel
- Meng, Alex
- Ravits, John
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tdp-43 cryptic exons are highly variable between cell types
Elevated nuclear TDP-43 induces constitutive exon skipping
Predicting mutually exclusive spliced exons based on exon length, splice site and reading frame conservation, and exon sequence homology
Tracking the evolution of alternatively spliced exons within the Dscam family
A phylogenetic generalized hidden Markov model for predicting alternatively spliced exons
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
Two alternatively-spliced human nebulin isoforms with either exon 143 or exon 144 and their developmental regulation
Assessing the number of ancestral alternatively spliced exons in the human genome
Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis
The era of cryptic exons: implications for ALS-FTD
HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
Tdp-43 cryptic exons are highly variable between cell types
Elevated nuclear TDP-43 induces constitutive exon skipping
Predicting mutually exclusive spliced exons based on exon length, splice site and reading frame conservation, and exon sequence homology
Tracking the evolution of alternatively spliced exons within the Dscam family
A phylogenetic generalized hidden Markov model for predicting alternatively spliced exons
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
Two alternatively-spliced human nebulin isoforms with either exon 143 or exon 144 and their developmental regulation
Assessing the number of ancestral alternatively spliced exons in the human genome
Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis
The era of cryptic exons: implications for ALS-FTD
HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
Tdp-43 cryptic exons are highly variable between cell types
Elevated nuclear TDP-43 induces constitutive exon skipping
Predicting mutually exclusive spliced exons based on exon length, splice site and reading frame conservation, and exon sequence homology
Tracking the evolution of alternatively spliced exons within the Dscam family
A phylogenetic generalized hidden Markov model for predicting alternatively spliced exons
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
Two alternatively-spliced human nebulin isoforms with either exon 143 or exon 144 and their developmental regulation
Assessing the number of ancestral alternatively spliced exons in the human genome
Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis
The era of cryptic exons: implications for ALS-FTD
HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases